Costly Brain-Cancer Drug No Longer Covered by Medicare

  • 📰 WSJ
  • ⏱ Reading Time:
  • 79 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Brain-cancer drug Gleostine is no longer covered by Medicare Part D, leaving some patients struggling to cover full cost, which can run over $1,000 per pill

The seller of the brain-cancer drug Gleostine has pulled out of a federal discount program for Medicare patients, leaving some struggling to pay for a therapy that can cost as much as $1,000 per capsule.

Patients may seek financial assistance from Nextsource or third-party sources, and doctors can explore less-expensive treatment alternatives. However, the company’s move highlights the limits of federal actions to reduce drug prices as well as programs meantUnder federal law, drug companies must provide certain discounts to be eligible for reimbursement by the Medicare Part D drug benefit.

NextSource says it hasn’t denied any patients’ applications for assistance and isn’t aware of any issues with access to its product. The society also sent a letter to NextSource CEO Robert DiCrisci in February, urging the company to rejoin Part D. The society shared a copy of the letter with The Wall Street Journal. NextSource didn’t respond to the letter, said a spokesman for the society.

An investigation by the Journal in 2017 showed how NextSource repeatedly hiked Gleostine prices, sparking outrage from doctors and patientsIn 2019, Medicare issued two fines to NextSource, totaling $117,206, for the company’s alleged failure to pay its share of drug costs under Part D within the required time frame in late 2018 and early 2019, according to letters the agency posted online. NextSource paid the penalties, a spokesman for the Medicare agency said.

Several of the nearly 40 study sites have had difficulty enrolling patients because of Gleostine’s cost, said Ashley Powell, director of the trial’s operations. The organization is having discussions with NextSource to address the issue, Ms. Powell said. NextSource confirmed the discussions.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

No prior authorization or appeals for Medicare … ahh Medicare for all, will take care of the overpopulation problem.

A Call to Protect People and Nature! T'h'a'c'k'e'r Pass, Nevada, Thread to Watch/read:

For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to her kimberlyalr88 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success

And this is Democracy for you people? Leaving vulnerable people unprotected, what about Biden's helath care pkg?

Shame, BIDEN needs to fix health insurance in the country!! FYI, or If you don’t know ... it’s a disaster!!

I started trading with Ms. Sharon Lauren with a minimum startup of $500 and I made $2850 in a period of 8days which I withdrew it successfully! I'm happy to meet you contact her via whatsapp +1(346)200-8687

Whhat but i thought government healthcare was the solution…lol

'Murica

Disgusting

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in HEALTH

Health Health Latest News, Health Health Headlines